CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report)’s share price was down 5.5% during trading on Thursday . The company traded as low as $0.24 and last traded at $0.25. Approximately 1,109,603 shares changed hands during trading, a decline of 61% from the average daily volume of 2,870,009 shares. The stock had previously closed at $0.27.
CERo Therapeutics Trading Down 5.5 %
The company has a 50 day moving average of $0.83.
CERo Therapeutics Company Profile
CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Featured Articles
- Five stocks we like better than CERo Therapeutics
- Profitably Trade Stocks at 52-Week Highs
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- What is a Bond Market Holiday? How to Invest and Trade
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Canadian Penny Stocks: Can They Make You Rich?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
